So we anticipate significant increase in adoption into this calendar year and beyond, not to mention theres clinical trials going on for new formats of the drug, like a once a year annual injection
However, the regulatory environment in Canada, specifically the restrictions in British Columbia and the complexities of international shipping, make it a risky choice for many Americans
They cover these medications to potentially reduce overall health risks and associated healthcare costs, recognizing the positive impact on patients' health and well-being
As a result, therapeutic strategies that simultaneously target glycaemic control and weight reduction have become increasingly important in managing overall cardiometabolic risk
Specialty drugs have additional barriers: restricted distribution networks controlled by manufacturers through REMS programs and limited distribution agreements that prevent a cost-plus model from accessing the products at all